MedPath
TGA Approval

TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension (188016)

188016

TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension

Roche Products Pty Ltd

May 11, 2012

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/7952bccbd84f77e6e74feb5d9a52ac98.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/db71655b5004e10b33ad6b2e9d52c37d.pdf

Active Ingredients

oseltamivir phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension (188016) - TGA 批准文号 | MedPath